• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fluorouracil/salicylic acid (Actikerall®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atorvastatin (Lipitor®) chewable tablets
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trastuzumab (Herceptin®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linagliptin (Trajenta®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Esomeprazole (Nexium® IV)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Adalimumab (Humira®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Capsaicin 8% patch (Qutenza®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Entecavir (Baraclude®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Icatibant (Firazyr®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Abiraterone (Zytiga®)
2012 NIHR Health Technology Assessment programme Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
2012 Belgian Health Care Knowledge Centre (KCE) Belgian guidelines for economic evaluations and budget impact analyses: second edition
2012 HAYES, Inc. Cognitive-behavioral therapy for bulimia nervosa
2012 HAYES, Inc. Coronary artery calcium scoring to assess the risk of coronary artery disease in asymptomatic adults
2012 NIHR Horizon Scanning Centre (NIHR HSC) Sebelipase alfa for lysosomal acid lipase deficiency
2012 HAYES, Inc. Custom total knee arthroplasty
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rilpivirine (Edurant®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rifaximin (Xifaxanta®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Nevirapine (Viramune®)
2012 NIHR Health Technology Assessment programme Vemurafenib for the treatment of locally advanced or metastatic BRAF V600E mutation positive malignant melanoma
2012 NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Fostamatinib for rheumatoid arthritis – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for dry eye syndrome
2012 NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone posterior segment drug delivery system (Ozurdex) for diabetic macular oedema– first or second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Ciclosporin A (Cyclokat) for keratoconjunctivitis sicca
2012 NIHR Horizon Scanning Centre (NIHR HSC) Bitopertin for schizophrenia: primary, persistent negative symptoms; sub-optimally controlled positive symptoms – in combination with antipsychotics
2012 NIHR Horizon Scanning Centre (NIHR HSC) BI 201335 for chronic hepatitis C infection
2012 NIHR Horizon Scanning Centre (NIHR HSC) Racecadotril for acute diarrhoea: infants (older than 3 months), children and adults – add on to oral rehydration therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Peginesatide for anaemia in chronic kidney disease – first and second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2012 NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) with capecitabine for advanced breast cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab emtansine in combination with pertuzumab for HER2-positive metastatic breast cancer – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab with chlorambucil for chronic lymphocytic leukaemia– first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for gastrointestinal stromal tumours – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for malignant melanoma – first line adjuvant therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) GSK1572932A for non-small cell lung cancer (NSCLC): melanoma-associated antigen 3 (MAGE-A3) positive; stage IB, II or IIIA – adjuvant therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Genesis™ implantable pulse generator for chronic migraine
2012 HAYES, Inc. High-frequency chest wall compression for cystic fibrosis
2012 HAYES, Inc. Human papillomavirus (HPV) genotyping to test for the presence of HPV 16 and 18 in women
2012 HAYES, Inc. Hydrogen breath test for irritable bowel syndrome
2012 HAYES, Inc. Interferon-gamma release assays for tuberculosis
2012 HAYES, Inc. Lee Silverman voice treatment for speech and voice problems in parkinson's disease
2012 HAYES, Inc. Mannitol bronchial provocation challenge for asthma
2012 HAYES, Inc. Occipital nerve stimulation for chronic cluster headache and chronic migraine headache
2012 HAYES, Inc. Mosaicplasty
2012 HAYES, Inc. Palivizumab (Synagis®) prophylaxis for respiratory syncytial virus infection in preterm infants
2012 HAYES, Inc. Percutaneous kyphoplasty
2012 HAYES, Inc. Percutaneous vertebroplasty
2012 HAYES, Inc. Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
2012 HAYES, Inc. Topical antiseptic products for preoperative skin preparation
2012 HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2012 HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2012 HAYES, Inc. Whole body vibration for the promotion of bone growth in postmenopausal women
2012 HAYES, Inc. Complement factor H (CFH) p.Tyr402His and age-related maculopathy susceptibility 2 (ARMS2) p.Ala69Ser polymorphism testing for susceptibility to age-related macular degeneration (AMD)
2012 HAYES, Inc. Cytochrome P450 21A2 (CYP21A2) testing in congenital adrenal hyperplasia
2012 HAYES, Inc. Factor V (F5) HR2 haplotype testing for hypercoagulability
2012 HAYES, Inc. Factor VII (F7) p.Arg353Gln polymorphism testing
2012 HAYES, Inc. Factor XIIIA1 (F13A1) p.Val34Leu polymorphism testing
2012 HAYES, Inc. KRAS sequence variant analysis for predicting response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the treatment of non-small cell lung cancer (NSCLC)
2012 HAYES, Inc. Ryanodine receptor 1 (RYR1) testing for malignant hyperthermia susceptibility (MHS)
2012 HAYES, Inc. Septin 9 (SEPT9) methylation analysis for colorectal cancer
2012 HAYES, Inc. TP63-related disorders (ectrodactyly-ectodermal dysplasia-clefting [EEC3] syndrome; acro-dermato-ungual-lacrimal-tooth [ADULT] syndrome; ankyloblepharon-ectodermal dysplasia-clefting [AEC; hay-wells] syndrome; limb-mammary syndrome (LMS); nonsyndromic split-hand/split-foot malformation [SHFM4]; rapp-hodgkin syndrome [RHS])
2012 HAYES, Inc. Aquamantys system with transcollation technology (Medtronic Inc.) for hip arthroplasty
2012 HAYES, Inc. Aquamantys system with transcollation technology (Medtronic Inc.) for liver resection
2012 HAYES, Inc. Argon plasma coagulation for hemostasis in patients with gastric antral vascular ectasia (GAVE)
2012 HAYES, Inc. Autologous fat grafting for postmastectomy breast reconstruction
2012 HAYES, Inc. AxiaLIF (Axial Lumbar Interbody Fusion) system (TranS1 Inc.) for percutaneous lumbosacral surgery
2012 HAYES, Inc. Cook celect vena cava filter (Cook Medical Inc.) for prophylaxis and treatment of pulmonary embolism
2012 HAYES, Inc. Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for patients with hepatocellular carcinoma (HCC)
2012 HAYES, Inc. Ganz trochanteric flip osteotomy approach to hip resurfacing for treatment of osteoarthritis
2012 HAYES, Inc. Home-based cervical traction for treatment of neck pain
2012 HAYES, Inc. Lifevest system (Asahi Kasei Corp.) wearable cardiac defibrillator for prevention of sudden cardiac arrest
2012 HAYES, Inc. Minimally invasive lumbar decompression (mild; Vertos Medical Inc.) for lumbar spinal stenosis
2012 HAYES, Inc. Outpatient cervical traction for treatment of neck pain
2012 HAYES, Inc. Tearlab osmolarity system (TearLab Corp.) for diagnosis of dry eye disease
2012 HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Belatacept (Nulojix®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/rilpivirine/tenofovir (Eviplera®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Everolimus (Afinitor®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dihydroartemisinin/piperaquine phosphate (Eurartesim®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dexmedetomidine (Dexdor®)
2012 Agency for Healthcare Research and Quality (AHRQ) Methods for insulin delivery and glucose monitoring: comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 report
2012 Agency for Healthcare Research and Quality (AHRQ) Venous thromboembolism prophylaxis in orthopedic surgery
2012 Agency for Healthcare Research and Quality (AHRQ) Antinuclear antibody, rheumatoid factor, and cyclic-citrullinated peptide tests for evaluating musculoskeletal complaints in children
2012 Agency for Healthcare Research and Quality (AHRQ) First- and second- generation antipsychotics for children and young adults
2012 Agency for Healthcare Research and Quality (AHRQ) Self-measured blood pressure monitoring: comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Noncyclic chronic pelvic pain therapies for women: comparative effectiveness
2012 Medical Advisory Secretariat (MAS) Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Chronic obstructive pulmonary disease (COPD) evidentiary framework
2012 Medical Advisory Secretariat (MAS) Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review
2012 Medical Advisory Secretariat (MAS) Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Community-based multidisciplinary care for patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Noninvasive positive pressure ventilation for acute respiratory failure patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012 Medical Advisory Secretariat (MAS) Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis